Results

Total Results: 4,876 records

Showing results for "end stage renal".

4761. Sampling, Weighting, and Synthetization Methodologies (pdf file)
      pbrn.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-Sampling-Weighting-Synthetization-Methodologies.pdf
      December 01, 2023 - For Medicare, the coverage qualification reasons were “End-stage renal disease (ESRD),” “Disability … Discharge Status The discharge status describes the status of the person as of the service end date

4762. Sampling, Weighting, and Synthetization Methodologies (pdf file)
      cahps.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-Sampling-Weighting-Synthetization-Methodologies.pdf
      December 01, 2023 - For Medicare, the coverage qualification reasons were “End-stage renal disease (ESRD),” “Disability … Discharge Status The discharge status describes the status of the person as of the service end date

4763. Sampling, Weighting, and Synthetization Methodologies (pdf file)
      healthcare411.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-Sampling-Weighting-Synthetization-Methodologies.pdf
      December 01, 2023 - For Medicare, the coverage qualification reasons were “End-stage renal disease (ESRD),” “Disability … Discharge Status The discharge status describes the status of the person as of the service end date

4764. Sampling, Weighting, and Synthetization Methodologies (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-Sampling-Weighting-Synthetization-Methodologies.pdf
      December 01, 2023 - For Medicare, the coverage qualification reasons were “End-stage renal disease (ESRD),” “Disability … Discharge Status The discharge status describes the status of the person as of the service end date

4765. Mindfulness: Engaging Frontline Providers in Antimicrobial Stewardship (June 10, 2014) | Agency for Healthcare Research and Quality
      ce.effectivehealthcare.ahrq.gov/hai/cauti-tools/archived-webinars/mindfulness-transcript.html
      December 01, 2017 - And we know that in the vast majority of cases, it's the antibiotic exposure that sets the stage for … routinely meeting with our hospitalists to talk about anticoagulation dosing, dosing of antibiotics in renal … At the end of today's call if you could all take a moment to fill out an evaluation of today's webinar

4766. Continuous-Outcomes-Quantitative-Synthesis Methods (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/continuous-outcomes-quantitative-synthesis_methods.pdf
      March 01, 2011 - The summary of final key points and recommendations are presented in Table 2 at the end of this chapter … The two end points of IQR and range are not symmetric around median (or mean) if the distribution of … Allowing for uncertainty due to missing data in meta- analysis--part 1: two-stage methods. … alter the conclusions of a meta-analysis with continuous outcomes: a case study of changes in renal … monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal

4767. Continuous-Outcomes-Quantitative-Synthesis Methods (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/continuous-outcomes-quantitative-synthesis_methods.pdf
      March 01, 2011 - The summary of final key points and recommendations are presented in Table 2 at the end of this chapter … The two end points of IQR and range are not symmetric around median (or mean) if the distribution of … Allowing for uncertainty due to missing data in meta- analysis--part 1: two-stage methods. … alter the conclusions of a meta-analysis with continuous outcomes: a case study of changes in renal … monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal

4768. Rapid Response: Efficacy of Dental Services for Reducing Adverse Events in Those Receiving Chemotherapy for Cancer (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-response-chemotherapy-dental.pdf
      July 01, 2023 - oral or dental examination performed on an inpatient basis as part of comprehensive workup prior to renal … the body’s immune system, leading to impairment of resistance to infections and other disorders.7 Renal … reviewer was unsure regarding the appropriate disposition of a study (either at the abstract or full-text stage … Response, a thorough search of the MEDLINE database compiled all relevant published studies through the end … Evidence-based Practice Center (EPC) Program using streamlined literature review methods to assist end-users

4769. Rapid Response: Efficacy of Dental Services for Reducing Adverse Events in Those Receiving Chemotherapy for Cancer (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rapid-response-chemotherapy-dental.pdf
      July 01, 2023 - oral or dental examination performed on an inpatient basis as part of comprehensive workup prior to renal … the body’s immune system, leading to impairment of resistance to infections and other disorders.7 Renal … reviewer was unsure regarding the appropriate disposition of a study (either at the abstract or full-text stage … Response, a thorough search of the MEDLINE database compiled all relevant published studies through the end … Evidence-based Practice Center (EPC) Program using streamlined literature review methods to assist end-users

4770. Home and Community-Based Services Quality Indicators: (pdf file)
      qualityindicators.ahrq.gov/Downloads/Resources/Publications/2012/Appendix_1A_Details_of_literature_review.pdf
      January 01, 2012 - References cited are listed at the end of each section. … One quarter of pressure ulcers in people with SCI are classified as severe (stage III or IV) (Caliri … However, as BMI increased, the prevalence of higher stage PU increased, suggesting that high BMI may … • Treatment strategies in geriatric populations should vary according to the stage of ulcer development … patients experienced multi-organ dysfunction with neurological impairment (100%), moderate-to-severe renal

4771. Assessing the Health and Welfare of the HCBS Population | Agency for Healthcare Research and Quality
      www.qualitymeasures.ahrq.gov/patient-safety/settings/long-term-care/resource/hcbs/findings/tab3b.html
      December 01, 2012 - Multiple Chronic Conditions On-Time Quality of Life Ambulatory Care End-Stage … Renal Disease (ESRD) Clinics Pharmacy Multiple Settings Quality Measures

4772. Archived: Final Evidence Summary: Thyroid Disease: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary49/thyroid-disease-screening-2004
      January 15, 2004 - Criteria Cooper et al., 1984 59 ( more details ) Previously treated Graves' disease, stage … good general health Subjects had higher TC, LDL, and ApoB levels than healthy controls Diabetes, renal … titrated up Placebo 11 (mean) 3.6-55.3 (range) mean TSH in control group increased to ~15 by the end

4773. 8 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
      November 01, 2008 - outcomes data, including data that showed no difference in gastrointestinal adverse events at the end … Development of instruments for assessing risk of bias specifically in studies of harms is still in an early stage … Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of

4774. 8 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
      November 01, 2008 - outcomes data, including data that showed no difference in gastrointestinal adverse events at the end … Development of instruments for assessing risk of bias specifically in studies of harms is still in an early stage … Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of

4775. 8 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
      November 01, 2008 - outcomes data, including data that showed no difference in gastrointestinal adverse events at the end … Development of instruments for assessing risk of bias specifically in studies of harms is still in an early stage … Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of

4776. 8 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
      November 01, 2008 - outcomes data, including data that showed no difference in gastrointestinal adverse events at the end … Development of instruments for assessing risk of bias specifically in studies of harms is still in an early stage … Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of

4777. ADHD Medications and Risk of Serious Coronary Heart Disease in Yough and Middle-Aged Adults (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
      January 01, 2023 - other than non-melanoma skin cancer), HIV infection, organ transplant, liver failure or hepatic coma, end-stage … renal disease, respiratory failure, or severe congestive heart failure. … included to reduce the potential for misclassification and referred to the first 30 days after the end … The former use category began after indeterminate use ended (i.e., at 31 days after end of current use … of insurance coverage/pharmacy benefit, day before 65th birthday, or end of study period (December

4778. ADHD Medications and Risk of Serious Coronary Heart Disease in Yough and Middle-Aged Adults (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
      January 01, 2023 - other than non-melanoma skin cancer), HIV infection, organ transplant, liver failure or hepatic coma, end-stage … renal disease, respiratory failure, or severe congestive heart failure. … included to reduce the potential for misclassification and referred to the first 30 days after the end … The former use category began after indeterminate use ended (i.e., at 31 days after end of current use … of insurance coverage/pharmacy benefit, day before 65th birthday, or end of study period (December

4779. Abnormal-Uterine-Bleeding Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
      March 01, 2013 - • Who are healthy, and without renal impairment, hepatic impairment, intestinal disease, thyroid

4780. Abnormal-Uterine-Bleeding Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
      March 01, 2013 - • Who are healthy, and without renal impairment, hepatic impairment, intestinal disease, thyroid